The expression of ASCT2 intensifies in patients with recurrent PCa post-ADT (26), ASCT2 is notably overexpressed in cancerous prostate cells and inhibiting ASCT2 could impair the tumor cell growth and development of metastases in PCa xenografts models (26). This evidence concerns the gene SLC1A5 and neoplasm.